Silvercrest Asset Management Group LLC Trims Stock Position in Humana Inc. (NYSE:HUM)

Silvercrest Asset Management Group LLC lowered its holdings in shares of Humana Inc. (NYSE:HUM) by 92.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,170 shares of the insurance provider’s stock after selling 114,218 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in Humana were worth $2,327,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. FPC Investment Advisory Inc. purchased a new stake in shares of Humana during the 4th quarter valued at about $27,000. Centricity Wealth Management LLC purchased a new stake in shares of Humana during the 4th quarter valued at about $30,000. LFA Lugano Financial Advisors SA increased its position in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management purchased a new stake in shares of Humana during the 4th quarter valued at about $33,000. Finally, Transce3nd LLC bought a new position in shares of Humana during the 4th quarter valued at approximately $38,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of recent research reports. Truist Financial cut their price objective on Humana from $325.00 to $305.00 and set a “hold” rating for the company in a research note on Monday, May 12th. Robert W. Baird boosted their price objective on Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, April 15th. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Mizuho boosted their price objective on Humana from $305.00 to $316.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Finally, Morgan Stanley cut their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $286.81.

Humana Stock Up 3.9%

NYSE HUM opened at $247.16 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market capitalization of $29.83 billion, a P/E ratio of 24.84, a P/E/G ratio of 2.05 and a beta of 0.49. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The stock has a 50 day moving average price of $262.90 and a 200-day moving average price of $269.48.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $7.23 EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.43%. Humana’s dividend payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.